Related references
Note: Only part of the references are listed.(Pro)renin Receptor-Mediated Signal Transduction and Tissue Renin-Angiotensin System Contribute to Diabetes-Induced Retinal Inflammation
Shingo Satofuka et al.
DIABETES (2009)
Direct Renin Inhibition Improves Systemic Insulin Resistance and Skeletal Muscle Glucose Transport in a Transgenic Rodent Model of Tissue Renin Overexpression
Guido Lastra et al.
ENDOCRINOLOGY (2009)
Angiotensin II induces vascular endothelial growth factor synthesis in mesenchymal stem cells
Rui-Zhen Shi et al.
EXPERIMENTAL CELL RESEARCH (2009)
Hyperreninemia Characterizing Women with Polycystic Ovary Syndrome Improves after Metformin Therapy
Evanthia Diamanti-Kandarakis et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2009)
Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production
Vivek P. Singh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Renin Inhibition Attenuates Insulin Resistance, Oxidative Stress, and Pancreatic Remodeling in the Transgenic Ren2 Rat
Javad Habibi et al.
ENDOCRINOLOGY (2008)
Aliskiren combined with losartan in type 2 diabetes and nephropathy
Hans-Henrik Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Aliskiren and dual therapy in type 2 diabetes mellitus
Julie R. Ingelfinger
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin
Nobuyuki Takahashi et al.
CELL METABOLISM (2007)
Structure-based drug design and the discovery of Aliskiren (Tekturna®):: Perseverance and creativity to overcome a R&D pipeline challenge
Nissim Claude Cohen
CHEMICAL BIOLOGY & DRUG DESIGN (2007)
Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats
D. J. Kelly et al.
DIABETOLOGIA (2007)
Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions
Andrew Advani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial
Suzanne Oparil et al.
LANCET (2007)
Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice
Cheol Whee Park et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker
Eoin O'Brien et al.
HYPERTENSION (2007)
Renin inhibition with aliskiren provides additive anti hypertensive efficacy when used in combination with hydrochlorothiazide
Alberto Villamil et al.
JOURNAL OF HYPERTENSION (2007)
Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes
Gregory Proctor et al.
DIABETES (2006)
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial
Sverre E. Kjeldsen et al.
JOURNAL OF HYPERTENSION (2006)
Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats
Sang-Youb Han et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
G Remuzzi et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Angiotensin II type 1 receptor blockade improves β-cell function and glucose tolerance in a mouse model of type 2 diabetes
KY Chu et al.
DIABETES (2006)
Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats
B Pilz et al.
HYPERTENSION (2005)
Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems
W Xiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets
T Lau et al.
DIABETOLOGIA (2004)
Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats
DR Cha et al.
JOURNAL OF ENDOCRINOLOGY (2004)
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus - Part 1. A meta-analysis of randomised clinical trials
AJ Scheen
DIABETES & METABOLISM (2004)
High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells
DB Vidotti et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
PPAR-α effects on the heart and other vascular tissues
GA Francis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension
M Furuhashi et al.
HYPERTENSION (2003)
Lipotoxicity: when tissues overeat
JE Schaffer
CURRENT OPINION IN LIPIDOLOGY (2003)
Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren
A Stanton et al.
HYPERTENSION (2003)
Renin similar to the submaxillary gland form is expressed in mouse mesangial cells: Subcellular localization and all generation under control and glucose-stimulated conditions
CA Leite et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2003)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure
L Barlucchi et al.
CIRCULATION RESEARCH (2001)
Share Paper
